1. Reconstitution of Intestinal CD4 and Th17 T Cells in Antiretroviral Therapy Suppressed HIV-Infected Subjects: Implication for Residual Immune Activation from the Results of a Clinical Trial.
- Author
-
d'Ettorre, Gabriella, Baroncelli, Silvia, Micci, Luca, Ceccarelli, Giancarlo, Andreotti, Mauro, Sharma, Prachi, Fanello, Gianfranco, Fiocca, Fausto, Cavallari, Eugenio Nelson, Giustini, Noemi, Mallano, Alessandra, Galluzzo, Clementina M., Vella, Stefano, Mastroianni, Claudio M., Silvestri, Guido, Paiardini, Mirko, and Vullo, Vincenzo
- Subjects
HIV infections ,T cells ,LYMPHOCYTES ,ANTIRETROVIRAL agents ,ANTI-HIV agents ,IMMUNE response - Abstract
Introduction: During HIV infection the severe depletion of intestinal CD4
+ T-cells is associated with microbial translocation, systemic immune activation, and disease progression. This study examined intestinal and peripheral CD4+ T-cell subsets reconstitution under combined antiretroviral therapy (cART), and systemic immune activation markers. Methods: This longitudinal single-arm pilot study evaluates CD4+ T cells, including Th1 and Th17, in gut and blood and soluble markers for inflammation in HIV-infected individuals before (M0) and after eight (M8) months of cART. From January 2010 to December 2011, 10 HIV-1 naïve patients were screened and 9 enrolled. Blood and gut CD4+ T-cells subsets and cellular immune activation were determined by flow-cytometry and plasma soluble CD14 by ELISA. CD4+ Th17 cells were detected in gut biopsies by immunohistochemistry. Microbial translocation was measured by limulus-amebocyte-lysate assay to detect bacterial lipopolysaccharide (LPS) and PCR Real Time to detect plasma bacterial 16S rDNA. Results: Eight months of cART increased intestinal CD4+ and Th17 cells and reduced levels of T-cell activation and proliferation. The magnitude of intestinal CD4+ T-cell reconstitution correlated with the reduction of plasma LPS. Importantly, the magnitude of Th17 cells reconstitution correlated directly with blood CD4+ T-cell recovery. Conclusion: Short-term antiretroviral therapy resulted in a significant increase in the levels of total and Th17 CD4+ T-cells in the gut mucosa and in decline of T-cell activation. The observation that pre-treatment levels of CD4+ and of CD8+ T-cell activation are predictors of the magnitude of Th17 cell reconstitution following cART provides further rationale for an early initiation of cART in HIV-infected individuals. Trial Registration: ClinicalTrials.gov [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF